Promoter hypermethylation in circulating
β
Morgan RouprΓͺt; Vincent Hupertan; James W.F. Catto; David R. Yates; Ishtiaq Rehm
π
Article
π
2007
π
John Wiley and Sons
π
French
β 185 KB
## Abstract Promoter hypermethylation of circulating cell DNA has been advocated as a diagnostic marker for prostate cancer, but its prognostic use is currently unclear. To assess this role, we compared hypermethylation of circulating cell DNA from prostate cancer patients with (Group 1, __n__ = 20